Library — CHDR

Search

Filter

The Neurotoxicity Scale: the validity of a patient-based scale, assessing neurotoxicity.

Aldenkamp AP, Baker G, Pieters MS, Schoemaker HC, Cohen AF, Schwabe S

Epilepsy research, 1995 Feb; 20(3):229-39

View publication
The effects of an ACTH (4-9) analogue on development of cisplatin neuropathy in testicular cancer: a randomized trial.

van Gerven JM, Hovestadt A, Moll JW, Rodenburg CJ, Splinter TA, van Oosterom AT, Keizer L, Drogendijk TE, Groenhout CM, Vecht CJ

Journal of neurology, 1994 May; 241(7):432-5

View publication
Effects of aldose reductase inhibition with tolrestat on diabetic retinopathy in a six months double blind trial.

van Gerven JM, Boot JP, Lemkes HH, van Best JA

Documenta ophthalmologica. Advances in ophthalmology, 1994 Apr; 87(4):355-65

View publication
Tinnitus suppression by intravenous lidocaine in relation to its plasma concentration.

den Hartigh J, Hilders CG, Schoemaker RC, Hulshof JH, Cohen AF, Vermeij P

Clinical pharmacology and therapeutics, 1993 Sep; 54(4):415-20

View publication
Pharmacodynamic interactions of diazepam and intravenous alcohol at pseudo steady state.

van Steveninck AL, Gieschke R, Schoemaker HC, Pieters MS, Kroon JM, Breimer DD, Cohen AF

Psychopharmacology, 1993 Apr; 110(4):471-8

View publication
Carbamazepine and lamotrigine in healthy volunteers: relevance to early tolerance and clinical trial dosage.

Hamilton MJ, Cohen AF, Yuen AW, Harkin N, Land G, Weatherley BC, Peck AW

Epilepsia, 1993 Apr; 34(1):166-73

View publication
Effects of temazepam on saccadic eye movements: concentration-effect relationships in individual volunteers.

van Steveninck AL, Verver S, Schoemaker HC, Pieters MS, Kroon R, Breimer DD, Cohen AF

Clinical pharmacology and therapeutics, 1992 Sep; 52(4):402-8

View publication
Pharmacokinetic-pharmacodynamic modeling of the central nervous system effects of midazolam and its main metabolite alpha-hydroxymidazolam in healthy volunteers.

Mandema JW, Tuk B, van Steveninck AL, Breimer DD, Cohen AF, Danhof M

Clinical pharmacology and therapeutics, 1992 May; 51(6):715-28

View publication
A multicentre trial of the aldose-reductase inhibitor tolrestat, in patients with symptomatic diabetic peripheral neuropathy. North European Tolrestat Study Group.

Macleod AF, Boulton AJ, Owens DR, Van Rooy P, Van Gerven JM, Macrury S, Scarpello JH, Segers O, Heller SR, Van Der Veen EA

Diabete & metabolisme, 1992 Apr; 18(1):14-20

View publication

«
1
2
...
10
11
12
13
14
15
16
17
18
»